BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 19699875)

  • 1. B-type natriuretic peptide-guided management and outcome in patients with obesity and dyspnea--results from the BASEL study.
    Noveanu M; Breidthardt T; Cayir S; Potocki M; Laule K; Mueller C
    Am Heart J; 2009 Sep; 158(3):488-95. PubMed ID: 19699875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study.
    Daniels LB; Clopton P; Bhalla V; Krishnaswamy P; Nowak RM; McCord J; Hollander JE; Duc P; Omland T; Storrow AB; Abraham WT; Wu AH; Steg PG; Westheim A; Knudsen CW; Perez A; Kazanegra R; Herrmann HC; McCullough PA; Maisel AS
    Am Heart J; 2006 May; 151(5):999-1005. PubMed ID: 16644321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
    Krauser DG; Lloyd-Jones DM; Chae CU; Cameron R; Anwaruddin S; Baggish AL; Chen A; Tung R; Januzzi JL
    Am Heart J; 2005 Apr; 149(4):744-50. PubMed ID: 15990762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of history of heart failure on diagnostic and prognostic value of BNP: results from the B-type Natriuretic Peptide for Acute Shortness of Breath Evaluation (BASEL) study.
    Boldanova T; Noveanu M; Breidthardt T; Potocki M; Reichlin T; Taegtmeyer A; Christ M; Laule K; Stelzig C; Mueller C
    Int J Cardiol; 2010 Jul; 142(3):265-72. PubMed ID: 19185372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of systemic hypertension on the diagnostic performance of B-type natriuretic peptide in patients with acute dyspnea.
    Pahle AS; Sørli D; Omland T; Knudsen CW; Westheim A; Wu AH; Steg PG; McCord J; Nowak RM; Hollander JE; Storrow AB; Abraham WT; McCullough PA; Maisel A
    Am J Cardiol; 2009 Oct; 104(7):966-71. PubMed ID: 19766765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-type natriuretic peptide levels in obese patients with advanced heart failure.
    Horwich TB; Hamilton MA; Fonarow GC
    J Am Coll Cardiol; 2006 Jan; 47(1):85-90. PubMed ID: 16386669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.
    Maisel A; Hollander JE; Guss D; McCullough P; Nowak R; Green G; Saltzberg M; Ellison SR; Bhalla MA; Bhalla V; Clopton P; Jesse R;
    J Am Coll Cardiol; 2004 Sep; 44(6):1328-33. PubMed ID: 15364340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender-specific risk stratification with B-type natriuretic peptide levels in patients with acute dyspnea: insights from the B-type natriuretic peptide for acute shortness of breath evaluation study.
    Christ M; Laule-Kilian K; Hochholzer W; Klima T; Breidthardt T; Perruchoud AP; Mueller C
    J Am Coll Cardiol; 2006 Nov; 48(9):1808-12. PubMed ID: 17084254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
    Maisel A; Mueller C; Nowak R; Peacock WF; Landsberg JW; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng L; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Terracciano G; Kremastinos D; Hartmann O; von Haehling S; Bergmann A; Morgenthaler NG; Anker SD
    J Am Coll Cardiol; 2010 May; 55(19):2062-76. PubMed ID: 20447528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of B-type natriuretic peptide testing in patients with acute dyspnea.
    Mueller C; Laule-Kilian K; Schindler C; Klima T; Frana B; Rodriguez D; Scholer A; Christ M; Perruchoud AP
    Arch Intern Med; 2006 May; 166(10):1081-7. PubMed ID: 16717170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term prognostic value of B-type natriuretic peptide in cardiac and non-cardiac causes of acute dyspnoea.
    Christ M; Thuerlimann A; Laule K; Klima T; Hochholzer W; Perruchoud AP; Mueller C
    Eur J Clin Invest; 2007 Nov; 37(11):834-41. PubMed ID: 17931382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of history of heart failure on diagnostic performance and utility of B-type natriuretic peptide testing for acute dyspnea in the emergency department.
    Chung T; Sindone A; Foo F; Dwyer A; Paoloni R; Janu MR; Wong H; Hall J; Freedman SB
    Am Heart J; 2006 Nov; 152(5):949-55. PubMed ID: 17070166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of brain natriuretic peptide and probrain natriuretic peptide in the diagnosis of cardiogenic pulmonary edema in patients aged 65 and older.
    Ray P; Arthaud M; Birolleau S; Isnard R; Lefort Y; Boddaert J; Riou B
    J Am Geriatr Soc; 2005 Apr; 53(4):643-8. PubMed ID: 15817011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic value of uric acid in patients with acute dyspnea.
    Reichlin T; Potocki M; Breidthardt T; Noveanu M; Hartwiger S; Burri E; Klima T; Stelzig C; Laule K; Mebazaa A; Christ M; Mueller C
    Am J Med; 2009 Nov; 122(11):1054.e7-1054.e14. PubMed ID: 19854335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of B-type natriuretic peptide in the management of elderly patients with acute dyspnoea.
    Mueller C; Laule-Kilian K; Frana B; Rodriguez D; Rudez J; Scholer A; Buser P; Pfisterer M; Perruchoud AP
    J Intern Med; 2005 Jul; 258(1):77-85. PubMed ID: 15953135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimarker strategy for risk prediction in patients presenting with acute dyspnea to the emergency department.
    Christ M; Laule K; Klima T; Hochholzer W; Breidthardt T; Perruchoud AP; Mueller C
    Int J Cardiol; 2008 May; 126(1):73-8. PubMed ID: 17481748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness of B-type natriuretic peptide (BNP) for the diagnosis of new-onset heart failure with a preserved left ventricular systolic function in longstanding hypertensive patients with acute dyspnea].
    Arquès S; Roux E; Sbragia P; Pieri B; Gélisse R; Luccioni R; Ambrosi P
    Arch Mal Coeur Vaiss; 2007 Feb; 100(2):113-20. PubMed ID: 17474496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study.
    McCullough PA; Duc P; Omland T; McCord J; Nowak RM; Hollander JE; Herrmann HC; Steg PG; Westheim A; Knudsen CW; Storrow AB; Abraham WT; Lamba S; Wu AH; Perez A; Clopton P; Krishnaswamy P; Kazanegra R; Maisel AS;
    Am J Kidney Dis; 2003 Mar; 41(3):571-9. PubMed ID: 12612980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of B-type natriuretic peptide for the management of women with dyspnea.
    Mueller C; Laule-Kilian K; Scholer A; Frana B; Rodriguez D; Schindler C; Marsch S; Perruchoud AP
    Am J Cardiol; 2004 Dec; 94(12):1510-4. PubMed ID: 15589006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between obesity and B-type natriuretic peptide levels.
    McCord J; Mundy BJ; Hudson MP; Maisel AS; Hollander JE; Abraham WT; Steg PG; Omland T; Knudsen CW; Sandberg KR; McCullough PA;
    Arch Intern Med; 2004 Nov; 164(20):2247-52. PubMed ID: 15534162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.